Indonesia鈥檚 Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces
Philips (NYSE: PHG) has secured landmark agreements with Indonesia's Ministry of Health to deploy advanced Azurion image-guided therapy systems across all 38 provinces. This nationwide initiative, part of the Strengthening Indonesia's Healthcare Referral Network (SIHREN) project, aims to transform treatment for heart disease, stroke, and cancer through minimally invasive care.
The project addresses healthcare accessibility challenges in Indonesia, the world's fourth most populous nation with over 280 million people spread across 17,000+ islands. The initiative comes as Indonesia faces rising non-communicable diseases projected to cost USD 4.47 trillion. Philips, employing over 3,900 people across 12 Indonesian cities, won the contract through an international competitive bidding process.
Philips (NYSE: PHG) ha siglato accordi storici con il Ministero della Salute indonesiano per l'installazione di avanzati sistemi di terapia guidata da immagini Azurion in tutte le 38 province del paese. Questa iniziativa nazionale, parte del progetto Rafforzamento della Rete di Riferimento Sanitaria in Indonesia (SIHREN), mira a rivoluzionare il trattamento di malattie cardiache, ictus e cancro attraverso cure minimamente invasive.
Il progetto affronta le difficolt脿 di accesso alle cure sanitarie in Indonesia, la quarta nazione pi霉 popolosa al mondo con oltre 280 milioni di abitanti distribuiti su pi霉 di 17.000 isole. L'iniziativa arriva in un momento in cui il paese deve far fronte all'aumento delle malattie non trasmissibili, il cui costo 猫 stimato in 4,47 trilioni di dollari USA. Philips, con oltre 3.900 dipendenti in 12 citt脿 indonesiane, ha ottenuto il contratto tramite un processo di gara internazionale competitivo.
Philips (NYSE: PHG) ha asegurado acuerdos hist贸ricos con el Ministerio de Salud de Indonesia para desplegar avanzados sistemas de terapia guiada por im谩genes Azurion en las 38 provincias del pa铆s. Esta iniciativa nacional, parte del proyecto Fortalecimiento de la Red de Referencia Sanitaria de Indonesia (SIHREN), busca transformar el tratamiento de enfermedades card铆acas, accidentes cerebrovasculares y c谩ncer mediante cuidados m铆nimamente invasivos.
El proyecto aborda los desaf铆os de accesibilidad sanitaria en Indonesia, la cuarta naci贸n m谩s poblada del mundo con m谩s de 280 millones de personas distribuidas en m谩s de 17.000 islas. La iniciativa surge en un contexto donde Indonesia enfrenta un aumento de enfermedades no transmisibles, cuyo costo se proyecta en 4,47 billones de d贸lares estadounidenses. Philips, con m谩s de 3.900 empleados en 12 ciudades indonesias, gan贸 el contrato mediante un proceso competitivo internacional.
頃勲鞀� (NYSE: PHG)電� 鞚鸽弰雱れ嫓鞎� 氤搓贝攵�鞕� 須嶊赴鞝侅澑 瓿勳暯鞚� 觳搓舶頃橃棳 鞝勱淡 38臧� 欤检棎 觳嫧 Azurion 鞓侅儊 鞙犽弰 旃橂 鞁滌姢韰�鞚� 氚办箻頃╇媹雼�. 鞚� 鞝勱淡鞝� 頂勲鞝濏姼電� 鞚鸽弰雱れ嫓鞎� 鞚橂 鞚橂 雱ろ姼鞗岉伂 臧曧檾(SIHREN) 靷梾鞚� 鞚柬櫂鞙茧, 斓滌唽 旃姷 旃橂毳� 韱淀暣 鞁灔氤�, 雵岇「欷�, 鞎� 旃橂毳� 順侅嫚頃橂姅 瓴冹潉 氇╉憸搿� 頃╇媹雼�.
鞚� 頂勲鞝濏姼電� 1鞏� 2,800毵� 氇� 鞚挫儊鞚� 鞚戈惮臧� 17,000臧� 鞚挫儊鞚� 靹棎 攵勴彫頃� 靹戈硠 4鞙� 鞚戈惮 雽�甑� 鞚鸽弰雱れ嫓鞎勳潣 鞚橂 鞝戧芳靹� 氍胳牅毳� 頃搓舶頃╇媹雼�. 鞚鸽弰雱れ嫓鞎勲姅 牍勳爠鞐检劚 歆堩櫂鞚� 歃濌皜頃棎 霐半澕 4臁� 4,700鞏� 雼煬(USD)鞚� 牍勳毄鞚� 鞓堨儊霅橂姅 靸來櫓鞛呺媹雼�. 頃勲鞀る姅 鞚鸽弰雱れ嫓鞎� 12臧� 霃勳嫓鞐愳劀 3,900氇� 鞚挫儊鞚� 歆侅洂鞚� 瓿犾毄頃橁碃 鞛堨溂氅�, 甑牅 瓴届焷 鞛呾鞍 瓿检爼鞚� 韱淀暣 鞚� 瓿勳暯鞚� 霐半儓鞀惦媹雼�.
Philips (NYSE: PHG) a conclu des accords historiques avec le Minist猫re de la Sant茅 indon茅sien pour d茅ployer des syst猫mes de th茅rapie guid茅e par l'image Azurion avanc茅s dans les 38 provinces du pays. Cette initiative nationale, faisant partie du projet de Renforcement du R茅seau de R茅f茅rence des Soins de Sant茅 en Indon茅sie (SIHREN), vise 脿 transformer le traitement des maladies cardiaques, des AVC et du cancer gr芒ce 脿 des soins peu invasifs.
Le projet r茅pond aux d茅fis d'accessibilit茅 aux soins en Indon茅sie, le quatri猫me pays le plus peupl茅 au monde avec plus de 280 millions d'habitants r茅partis sur plus de 17 000 卯les. Cette initiative intervient alors que l'Indon茅sie fait face 脿 une augmentation des maladies non transmissibles dont le co没t est estim茅 脿 4,47 billions de dollars US. Philips, employant plus de 3 900 personnes dans 12 villes indon茅siennes, a remport茅 le contrat 脿 l'issue d'un appel d'offres international comp茅titif.
Philips (NYSE: PHG) hat bahnbrechende Vereinbarungen mit dem indonesischen Gesundheitsministerium getroffen, um fortschrittliche Azurion bildgef眉hrte Therapiesysteme in allen 38 Provinzen einzuf眉hren. Diese landesweite Initiative, Teil des Projekts zur St盲rkung des indonesischen Gesundheits眉berweisungssystems (SIHREN), zielt darauf ab, die Behandlung von Herzkrankheiten, Schlaganf盲llen und Krebs durch minimalinvasive Verfahren zu revolutionieren.
Das Projekt adressiert die Herausforderungen der Gesundheitsversorgung in Indonesien, dem viertbev枚lkerungsreichsten Land der Welt mit 眉ber 280 Millionen Menschen auf mehr als 17.000 Inseln. Die Initiative kommt zu einer Zeit, in der Indonesien mit steigenden nicht 眉bertragbaren Krankheiten konfrontiert ist, deren Kosten auf 4,47 Billionen US-Dollar gesch盲tzt werden. Philips, mit 眉ber 3.900 Mitarbeitern in 12 indonesischen St盲dten, erhielt den Auftrag durch ein internationales wettbewerbliches Ausschreibungsverfahren.
- None.
- Significant infrastructure and training challenges in implementing systems across 17,000+ islands
- High economic burden of USD 4.47 trillion from non-communicable diseases indicates substantial healthcare costs
Insights
Philips wins major nationwide contract to deploy medical imaging systems across Indonesia, strengthening its foothold in Southeast Asia's largest market.
Philips has secured a landmark series of agreements with Indonesia's Ministry of Health to install its advanced Azurion image-guided therapy systems across all 38 provinces. This nationwide deployment represents a significant revenue opportunity for Philips in the world's fourth most populous country with over 280 million people.
The deal's structure is particularly favorable - these are long-term multiyear agreements awarded through competitive bidding, suggesting Philips outperformed rivals to secure this position. The agreements include not just equipment sales but also ongoing services and training, creating a sustainable revenue stream beyond the initial installation phase.
This initiative addresses Indonesia's growing burden of non-communicable diseases, which are projected to cost the economy
The deal enhances Philips' already substantial presence in Indonesia, where it employs 3,900 people across 12 cities and operates a manufacturing facility in Batam. This expanded footprint strengthens Philips' position in the fast-growing Southeast Asian healthcare market.
While financial terms weren't disclosed, the nationwide scale, long-term nature, and World Bank funding support suggest this represents a material contract win for Philips' image-guided therapy business. The agreement also demonstrates Philips' continued execution on its strategy to expand in growth markets while focusing on its core health technology portfolio after divesting its domestic appliances business.
July 29, 2025
- Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas
- Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia
- Combines cutting-edge treatment technology, services and training to strengthen Indonesia鈥檚 health infrastructure
Amsterdam, the Netherlands and Jakarta, Indonesia 鈥� In a major step toward transforming healthcare delivery, (NYSE: PHG, AEX: PHIA), a global leader in health technology and the Indonesia鈥檚 Ministry of Health today announced plans to deploy state-of-the-art image-guided therapy systems nationwide, as part of their signed agreements, under the Strengthening Indonesia鈥檚 Healthcare Referral Network (SIHREN) project.
The landmark agreements, recently awarded to Philips after an international, competitive bidding process, combine cutting-edge treatment technology, services and training to strengthen Indonesia鈥檚 health infrastructure. The initiative aims to transform the country鈥檚 treatment for heart disease, stroke and cancer 鈥� Indonesia鈥檚 leading causes of death 鈥� by expanding access to cutting-edge technologies and care in all 38 provinces, from Aceh to Papua. This initiative is set to benefit millions of patients across Indonesia.聽
The SIHREN project is an ambitious effort jointly funded by the World Bank and other multilateral development banks to support Indonesia鈥檚 health transformation agenda by significantly improving referral healthcare.
Challenges in ensuring equitable access to healthcare
With a population exceeding 280 million, Indonesia is the world鈥檚 fourth most populous nation. As a vast archipelago of over 17,000 islands, it faces significant challenges in ensuring equitable access to healthcare. The country is also grappling with a surge in non-communicable diseases (NCDs) such as heart disease, stroke and cancer 鈥� conditions projected to impose a staggering economic burden of USD 4.47 trillion [1]. And yet, advanced care for these illnesses remains largely centralized on the densely populated island of Java, leaving much of the country underserved.
The initiative will establish a nationwide network of advanced image-guided therapy rooms, dramatically expanding access to minimally invasive treatments across hundreds of hospitals in all 38 provinces. The Ministry of Health has made a long-term commitment to delivering nationwide coverage of the Azurion platform, aligned to local hospital infrastructure and patient population needs.
A study published in the Journal of Minimally Invasive Surgery [2] found that minimally invasive techniques significantly reduce postoperative pain, recovery time, and hospital stays compared to traditional open surgeries.
"Delivering better care for more people requires strong partnerships and the best innovations,鈥� said Roy Jakobs, CEO of Royal Philips. 鈥淲e鈥檙e honored to be Indonesia鈥檚 partner of choice to deliver our innovation directly where it's needed most. More patients in Indonesia will now have access to better care.鈥�
鈥淢inimally invasive care is life-changing for patients, unlocking treatment options that were once unimaginable. With small incisions, such targeted treatments can mean shorter hospital stays, fewer complications and quicker recoveries for patients,鈥� said Carla Goulart Peron, Chief Medical Officer at Philips. 鈥淔rom opening heart-attack-causing blockages, to treating strokes and targeting cancer tumors, image-guided, minimally invasive therapy will be a game-changer for NCD care in Indonesia.鈥�
Philips maintains a strong footprint in Indonesia, employing over 3,900 people across 12 cities and operating a manufacturing facility in Batam for its Personal Health businesses. The Philips Foundation recently launched聽 across the country.
鈥淲e remain committed to supporting healthcare transformation by delivering innovations that provide better outcome for patient and improve experience for healthcare workers,鈥� said Astri R. Dharmawan, President Director of Philips Indonesia. 鈥淥ur combined efforts with the Indonesian government will help close healthcare gaps and bring us closer to a Healthy Indonesia.鈥�
摆1闭听
[2]
For further information, please contact:
Michael Fuchs
Global External Relations Director, Philips
Tel.: +31 614 869 261
E-mail:
Jane Yeo
Head of Brand and Communications APAC, Philips
Tel.: +65 9618 7397
E-mail:
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people鈥檚 health and well-being through meaningful innovation. Philips鈥� patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at .
Attachments
FAQ
What is the scope of Philips' (PHG) healthcare agreement with Indonesia?
How many people will benefit from Philips' healthcare initiative in Indonesia?
What is Philips' current presence in Indonesia as of 2025?
How will Philips' Azurion systems impact patient care in Indonesia?
What is the economic impact of non-communicable diseases in Indonesia?
